image
Addex Therapeutics Ltd ADXN
Healthcare - Biotechnology - NASDAQ - CH
Watchlist
$ 8.06
-1.71 %
$ 12.7 M
Market Cap
-0.42
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 13.39% 49.26% 49.90%
Annual Report FY 10-K 2022-12-31 -51.22% -35.52% -32.34%
Annual Report FY 10-K 2021-12-31 -19.28% -19.39% -26.65%
Annual Report FY 10-K 2020-12-31 30.77% 13.00% 17.47%
Annual Report FY 10-K 2019-12-31 -54.29% -798.63% -941.28%
Annual Report FY 10-K 2018-12-31 1109.03% 49.86% 55.96%
Annual Report FY 10-K 2017-12-31 2784.73% -4.16% -3.37%
Annual Report FY 10-K 2016-12-31 -57.00% 25.09% 19.09%
Annual Report FY 10-K 2015-12-31 -52.81% -136.88% -115.29%
Annual Report FY 10-K 2014-12-31 -6.93% 87.73% 87.57%
Annual Report FY 10-K 2013-12-31 -24.22% 45.66% 46.47%
Annual Report FY 10-K 2012-12-31 -95.71% 14.55% 12.80%
Annual Report FY 10-K 2011-12-31 42.94% 7.44% 7.81%
Annual Report FY 10-K 2010-12-31 -51.71% 21.19% 21.96%
Annual Report FY 10-K 2009-12-31 -84.74% -93.47% -73.11%
Annual Report FY 10-K 2008-12-31 5405.28% 37.11% 33.89%
Annual Report FY 10-K 2007-12-31 -89.72% -70.78% -80.01%
Annual Report FY 10-K 2006-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2024-06-30 -81.73% 581.42% 64.69%
Quarterly Report Q1 8-K 2024-03-31 -53.10% -28.25% 67.16%
Quarterly Report Q4 8-K 2023-12-31 -74.10% 21.76% 23.33%
Quarterly Report Q3 8-K 2023-09-30 -19.95% 36.29% 36.34%
Quarterly Report Q2 8-K 2023-06-30 244.08% 62.95% 64.09%
Quarterly Report Q1 8-K 2023-03-31 111.14% 58.67% 58.36%
Quarterly Report Q4 8-K 2022-12-31 49.04% 17.46% 18.17%
Quarterly Report Q3 8-K 2022-09-30 -39.97% -14.16% -16.53%
Quarterly Report Q2 8-K 2022-06-30 -81.53% -53.97% -57.37%
Quarterly Report Q1 8-K 2022-03-31 -71.90% -120.63% -83.05%
Quarterly Report Q4 8-K 2021-12-31 -78.17% -108.20% -126.97%
Quarterly Report Q3 8-K 2021-09-30 2401.47% -8.61% -14.87%
Quarterly Report Q2 8-K 2021-06-30 15.31% -50.58% -51.54%
Quarterly Report Q1 8-K 2021-03-31 -6.62% 38.70% 26.32%
Quarterly Report Q4 8-K 2020-12-31 75.04% 41.86% 43.85%
Quarterly Report Q3 8-K 2020-09-30 -94.57% 7.59% 17.24%
Quarterly Report Q2 8-K 2020-06-30 65.72% 30.78% 31.85%
Quarterly Report Q1 8-K 2020-03-31 28.99% -41.60% -36.79%
Quarterly Report Q4 8-K 2019-12-31 55.80% -82.78% -72.82%
Quarterly Report Q3 8-K 2019-09-30 -24.75% -79.30% -93.77%
Quarterly Report Q2 8-K 2019-06-30 -80.65% -382.27% -355.10%
Quarterly Report Q1 8-K 2019-03-31 -73.88% -258.32% -254.17%
Quarterly Report Q4 8-K 2018-12-31 388.86% -167.81% -161.76%
Quarterly Report Q3 8-K 2018-09-30 388.86% -167.81% -161.76%
Quarterly Report Q2 8-K 2018-06-30 2266.98% 231.73% 240.31%
Quarterly Report Q1 8-K 2018-03-31 2266.98% 231.73% 240.31%
Quarterly Report Q4 8-K 2017-12-31 112.96% 10.29% 9.95%
Quarterly Report Q3 8-K 2017-09-30 112.96% 10.29% 9.95%
Quarterly Report Q2 8-K 2017-06-30 -20.01% -20.35% -18.17%
Quarterly Report Q1 8-K 2017-03-31 -20.01% -20.35% -18.17%
Quarterly Report Q4 8-K 2016-12-31 -81.73% -21.42% -55.32%
Quarterly Report Q3 8-K 2016-09-30 -81.73% -21.42% -55.32%
Quarterly Report Q2 8-K 2016-06-30 216.75% 47.59% 6.19%
Quarterly Report Q1 8-K 2016-03-31 216.74% 47.59% 6.19%
Quarterly Report Q4 8-K 2015-12-31 128.02% -70.38% 31.85%
Quarterly Report Q3 8-K 2015-09-30 128.02% -70.38% 31.85%
Quarterly Report Q2 8-K 2015-06-30 0.00% -192.01% -63.43%
Quarterly Report Q1 8-K 2015-03-31 0.00% -192.01% -63.43%
Quarterly Report Q4 8-K 2014-12-31 -88.78% -53.28% -196.27%
Quarterly Report Q3 8-K 2014-09-30 -88.78% -53.28% -196.27%
Quarterly Report Q2 8-K 2014-06-30 0.00% 93.04% 93.06%
Quarterly Report Q1 8-K 2014-03-31 0.00% 93.04% 93.06%
Quarterly Report Q4 8-K 2013-12-31 0.00% 95.52% 95.52%
Quarterly Report Q3 8-K 2013-09-30 0.00% 95.52% 95.52%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2012-09-30 0.00% 0.00% 0.00%